Current status of prosthetic bypass grafts: A review

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 74, Issue 1, 2005, Pages 570-581

  Kannan, Ruben Y ^a,b   Salacinski, Henryk J ^a   Butler, Peter E ^b   Hamilton, George ^b   Seifalian, Alexander M ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Dacron ; EPTFE; Microvessel; Polymer; Polypropylene; Polyurethane; Prosthesis; Vascular graft

Indexed keywords

BIOMATERIALS; POLYTETRAFLUOROETHYLENES; PROSTHETICS; TISSUE;

BIOMIMICRY; BYPASS GRAFTS; HYBRID PROSTHESES;

GRAFT COPOLYMERS;

DACRON; POLITEF; POLYMER; POLYPROPYLENE; POLYURETHAN;

BIOMIMETICS; BLOOD VESSEL DIAMETER; BLOOD VESSEL GRAFT; BLOOD VESSEL PROSTHESIS; BYPASS SURGERY; COMPLIANCE (PHYSICAL); FLOW RATE; MICROVASCULATURE; REVIEW; TISSUE ENGINEERING;

ANIMALS; ARTERIOVENOUS SHUNT, SURGICAL; BIOCOMPATIBLE MATERIALS; BLOOD VESSEL PROSTHESIS; GAMMA RAYS; GRAFT OCCLUSION, VASCULAR; HUMANS; MICROCIRCULATION; POLYMERS; POLYPROPYLENES; POLYTETRAFLUOROETHYLENE; POLYURETHANES; RENAL DIALYSIS;

EID: 21444443183     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.b.30247     Document Type: Review

References (131)

1. Baim DS. Percutaneous treatment of saphenous vein graft disease: the ongoing challenge. J Am Coll Cardiol 2003;42: 1370-1372.
2. Suma H. Arterial grafts in coronary bypass surgery. Ann Thorac Cardiovasc Surg 1999;5:141-145.
3. Lau H, Cheng SW. Is the preferential use of ePTFE grafts in femorofemoral bypass justified? Ann Vasc Surg 2001;15:383-387.
4. Brossollet LJ. Mechanical issues in vascular grafting: a review. Int J Artif Organs 1992;15:579-584.
5. Meinhart J, Deutsch M, Zilla P. Eight years of clinical endothelial cell transplantation. Closing the gap between prosthetic grafts and vein grafts. ASAIO J 1997;43:M515-M521.
6. Meinhart JG, Deutsch M, Fischlein T, Howanietz N, Froschl A, Zilla P. Clinical autologous in vitro endothelialization of 153 infrainguinal ePTFE grafts. Ann Thorac Surg 2001;71: S327-S331.
7. Budd JS, Allen KE, Hartley G, Bell PR. The effect of preformed confluent endothelial cell monolayers on the patency and thrombogenicity of small calibre vascular grafts. Eur J Vasc Surg 1991;5:397-405.
8. Demiri EC, Iordanidis SL, Mantinaos CF. Experimental use of prosthetic grafts in microvascular surgery. Handchir Mikrochir Plast Chir 1999;31:102-106.
9. Harris JR, Seikaly H. Evaluation of polytetrafluoroethylene micrografts in microvascular surgery. J Otolaryngol 2002;31: 89-92.
10. Schmedlen RH, Elbjeirami WM, Gobin AS, West JL. Tissue engineered small-diameter vascular grafts. Clin Plast Surg 2003;30:507-517.
11. Teebken OE, Pichlmaier AM, Haverich A. Cell seeded decellularised allogeneic matrix grafts and biodegradable polydioxanone-prostheses compared with arterial autografts in a porcine model. Eur J Vasc Endovasc Surg 2001;22:139-145.
12. Bourassa MG. Long-term vein graft patency. Curr Opin Cardiol 1994;9:685-691.
13. Baan J Jr, Thompson JM, Reul GJ, Cooley DA, Brand R, Henderson MC, et al. Vessel wall and flow characteristics after carotid endarterectomy: eversion endarterectomy compared with Dacron patch plasty. Eur J Vasc Endovasc Surg 1997;13: 583-591.
14. Salacinski HJ, Goldner S, Giudiceandrea A, Hamilton G, Seifalian AM, Edwards A, et al. The mechanical behavior of vascular grafts: a review. J Biomater Appl 2001;15:241-278.
15. Salacinski HJ, Odlyha M, Hamilton G, Seifalian AM. Thermomechanical analysis of a compliant poly(carbonate-urea)urethane after exposure to hydrolytic, oxidative, peroxidative and biological solutions. Biomaterials 2002;23:2231-2240.
16. Peng T, Gibula P, Yao KD, Goosen MF. Role of polymers in improving the results of stenting in coronary arteries. Biomaterials 1996;17:685-694.
17. Ku DN, Allen RC. Vascular grafts. In: Bronzino J, editor. The biomedical engineering handbook. Boca Raton, FL: CRC Press; 1995. p 1871-1878.
18. Cziperle DJ, Joyce KA, Tattersall CW, Henderson SC, Cabusao EB, Garfield JD, et al. Albumin impregnated vascular grafts: albumin resorption and tissue reactions. J Cardiovasc Surg (Torino) 1992;33:407-414.
19. Boss A, Stierli P. Dacron prosthesis dilatation. Case report and review of the literature. Helv Chir Acta 1993;60:153-156.
20. Matsumoto H, Sugiyama S, Shibazaki A, Tanaka R, Takashima K, Noishiki Y, et al. A long term comparison between Denacol EX-313-treated bovine jugular vein graft and ultrafine polyester fiber graft for reconstruction of tight ventricular outflow tract in dogs. J Vet Med Sci 2003;65:363-368.
21. Glowinski J, Glowinski S, Farbiszewski R, Makarewicz-Plonska M, Chwiecko M. Endogenic non-enzymatic antioxidative system of polyester grafts during their healing. J Cardiovasc Surg (Torino) 1997;38:465-471.
22. Kowalewski R, Zimnoch L, Wojtukiewicz MZ, Glowinski S, Glowinski J. Coagulation activators and inhibitors in the neointima of polyester vascular grafts. Blood Coagul Fibrinolysis 2003;14:433-439.
23. Fournier N, Doillon CJ. Biological molecule-impregnated polyester: an in vivo angiogenesis study. Biomaterials 1996; 17:1659-1665.
24. Prager M, Polterauer P, Bohmig HJ, Wagner O, Fugl A, Kretschmer G, et al. Collagen versus gelatin-coated Dacron versus stretch polytetrafluoroethylene in abdominal aortic bifurcation graft surgery: results of a seven-year prospective, randomized multicenter trial. Surgery 2001;130:408-414.
25. Taylor LM Jr, Edwards JM, Porter JM. Present status of reversed vein bypass grafting: five-year results of a modern series. J Vasc Surg 1990;11:193-205.
26. Akers DL, Du YH, Kempczinski RF. The effect of carbon coating and porosity on early patency of expanded polytetrafluoroethylene grafts: an experimental study. J Vasc Surg 1993;18:10-15.
27. Kohler TR, Stratton JR, Kirkman TR, Johansen KH, Zierler BK, Clowes AW. Conventional versus high-porosity polytetrafluoroethylene grafts: clinical evaluation. Surgery 1992;112: 901-907.
28. Wigod MD, Klitzman B. Quantification of in vitro endothelial cell adhesion to vascular graft material. J Biomed Mater Res 1993;27:1057-1062.
29. Greisler HP, Tattersall CW, Henderson SC, Cabusao EA, Garfield JD, Kim DU. Polypropylene small-diameter vascular grafts. J Biomed Mater Res 1992;26:1383-1394.
30. Zenni GC, Gray JL, Appelgren EO, Kim DU, Berceli S, Ligush J, et al. Modulation of myofibroblast proliferation by vascular prosthesis biomechanics. ASAIO J 1993;39:M496-M500.
31. Greisler HP, Tattersall CW, Klosak JJ, Cabusao EA, Garfield JD, Kim DU. Partially bioresorbable vascular grafts in dogs. Surgery 1991;110:645-654.
32. Tiwari A, Cheng K, Salacinski HJ, Hamilton G, Seifalian AM. Improving compliance at peripheral arterial and cardiovascular anastomosis: the effect of suture materials and techniques. Eur J Vasc Endovasc Surg 2003;25:325-329.
33. Zhang Z, Marois Y, Guidoin RG, Bull P, Marois M, How T, et al. Vascugraft polyurethane arterial prosthesis as femoropopliteal and femoro-peroneal bypasses in humans: pathological, structural and chemical analyses of four excised grafts. Biomaterials 1997;18:113-124.
34. Jeschke MG, Hermanutz V, Wolf SE, Koveker GB. Polyurethane vascular prostheses decreases neointimal formation compared with expanded polytetrafluoroethylene. J Vasc Surg 1999;29:168-176.
35. Wilson GJ, MacGregor DC, Klement P, Dereume JP, Weber BA, Binnington AG, et al. The composite Corethane/Dacron vascular prosthesis. Canine in vivo evaluation of 4 mm diameter grafts with 1 year follow-up. ASAIO Trans 1991;37: M475-M476.
36. Seifalian AM, Salacinski HJ, Tiwari A, Edwards A, Bowald S, Hamilton G. In vivo biostability of a poly(carbonate-urea)urethane graft. Biomaterials 2003;24:2549-2557.
37. Eberhart A, Zhang Z, Guidoin R, Laroche G, Guay L, De La FD, et al. A new generation of polyurethane vascular prostheses: rara avis or ignis fatuus? J Biomed Mater Res 1999;48: 546-558.
38. Gunatillake PA, Adhikari R. Biodegradable synthetic polymers for tissue engineering. Eur Cell Mater 2003;5:1-16.
39. Guan J, Sacks MS, Beckman EJ, Wagner WR. Synthesis, characterization, and cytocompatibility of elastomeric, biodegradable poly(ester-urethane)ureas based on poly(caprolactone) and putrescine. J Biomed Mater Res 2002;61:493-503.
40. Salacinski HJ, Tai NR, Carson RJ, Edwards A, Hamilton G, Seifalian AM. In vitro stability of a novel compliant poly(carbonate-urea)urethane to oxidative and hydrolytic stress. J Biomed Mater Res 2002;59:207-218.
41. Matsuda T, Nakayama Y. Surface microarchitectural design in biomedical applications: in vitro transmural endothelialization on microporous segmented polyurethane films fabricated using an excimer laser. J Biomed Mater Res 1996;31:235-242.
42. Ko IK, Iwata H. An approach to constructing three-dimensional tissue. Ann N Y Acad Sci 2001;944:443-455.
43. Kowligi RR, von Maltzahn WW, Eberhart RC. Fabrication and characterization of small-diameter vascular prostheses. J Biomed Mater Res 1988;22:245-256.
44. van der LB, Nieuwenhuis P, Molenaar I, Wildevuur CR. Long-term biologic fate of neoarteries regenerated in microporous, compliant, biodegradable, small-caliber vascular grafts in rats. Surgery 1987;101:459-467.
45. Greisler HP, Endean ED, Klosak JJ, Ellinger J, Dennis JW, Buttle K, et al. Polyglactin 910/polydioxanone bicomponent totally resorbable vascular prostheses. J Vasc Surg 1988;7: 697-705.
46. Izhar U, Schwalb H, Borman JB, Hellener GR, Hotoveli-Salomon A, Marom G, et al. Novel synthetic selectively degradable vascular prostheses: a preliminary implantation study. J Surg Res 2001;95:152-160.
47. Shinoka T, Shum-Tim D, Ma PX, Tanel RE, Isogai N, Langer R, et al. Creation of viable pulmonary artery autografts through tissue engineering. J Thorac Cardiovasc Surg 1998;115:536-545.
48. Shum-Tim D, Stock U, Hrkach J, Shinoka T, Lien J, Moses MA, et al. Tissue engineering of autologous aorta using a new biodegradable polymer. Ann Thorac Surg 1999;68: 2298-2304.
49. van der LB, Wildevuur CR. From a synthetic, microporous, compliant, biodegradable small-caliber vascular graft to a new artery. Thorac Cardiovasc Surg 1989;37:337-347.
50. Uchimura E, Sawa Y, Taketani S, Yamanaka Y, Hara M, Matsuda H, et al. Novel method of preparing acellular cardiovascular grafts by decellularization with poly(ethylene glycol). J Biomed Mater Res 2003;67A:834-837.
51. Tamura N, Nakamura T, Terai H, Iwakura A, Nomura S, Shimizu Y, et al. A new acellular vascular prosthesis as a scaffold for host tissue regeneration. Int J Artif Organs 2003; 26:783-792.
52. Nemcova S, Noel AA, Jost CJ, Gloviczki P, Miller VM, Brockbank KG. Evaluation of a xenogeneic acellular collagen matrix as a small-diameter vascular graft in dogs-preliminary observations. J Invest Surg 2001;14:321-330.
53. Kumar TR, Krishnan LK. A stable matrix for generation of tissue-engineered nonthrombogenic vascular grafts. Tissue Eng 2002;8:763-770.
54. Shi Q, Bhattacharya V, Hong-De Wu M, Sauvage LR. Utilizing granulocyte colony-stimulating factor to enhance vascular graft endothelialization from circulating blood cells. Ann Vasc Surg 2002;16:314-320.
55. Merzkirch C, Davies N, Zilla P. Engineering of vascular ingrowth matrices: are protein domains an alternative to peptides? Anat Rec 2001;263:379-387.
56. Tiwari A, Kidane A, Salacinski H, Punshon G, Hamilton G, Seifalian AM. Improving endothelial cell retention for single stage seeding of prosthetic grafts: use of polymer sequences of arginine-glycine-aspartate. Eur J Vasc Endovasc Surg 2003; 25:325-329.
57. Heilshorn SC, DiZio KA, Welsh ER, Tirrell DA. Endothelial cell adhesion to the fibronectin CS5 domain in artificial extracellular matrix proteins. Biomaterials 2003;24:4245-4252.
58. Lehle K, Buttstaedt J, Birnbaum DE. Expression of adhesion molecules and cytokines in vitro by endothelial cells seeded on various polymer surfaces coated with titaniumcarboxonitride. J Biomed Mater Res 2003;65A:393-401.
59. Boura C, Menu P, Payan E, Picart C, Voegel JC, Muller S, et al. Endothelial cells grown on thin polyelectrolyte mutlilayered films: an evaluation of a new versatile surface modification. Biomaterials 2003;24:3521-3530.
60. Miller DC, Thapa A, Haberstroh KM, Webster TJ. Endothelial and vascular smooth muscle cell function on poly(lactic-co-glycolic acid) with nano-structured surface features. Biomaterials 2004;25:53-61.
61. Xue L, Greisler HP. Biomaterials in the development and future of vascular grafts. J Vasc Surg 2003;37:472-480.
62. Sala F, Hassen-Khodja R, Lecis A, Bouillanne PJ, Declemy S, Batt M. Long-term outcome of femoral above-knee popliteal artery bypass using autologous saphenous vein versus expanded polytetrafluoroethylene grafts. Ann Vasc Surg 2003; 17:401-407.
63. Fisher RK, Kirkpatrick UJ, How TV, Brennan JA, Gilling-Smith GL, Harris PL. The distaflo graft: a valid alternative to interposition vein? Eur J Vasc Endovasc Surg 2003;25:235-239.
64. Lu CH, Chang J, Lai ST, Shin CC. Comparative evaluation of stretch and non-stretch polytetrafluorethylene (PTFE) prosthetic grafts for femoro-popliteal bypass. Zhonghua Yi Xue Za Zhi (Taipei) 2002;65:200-204.
65. Green RM, Abbott WM, Matsumoto T, Wheeler JR, Miller N, Veith FJ, et al. Prosthetic above-knee femoropopliteal bypass grafting: five-year results of a randomized trial. J Vasc Surg 2000;31:417-425.
66. Miyazaki K, Nishibe T, Sata F, Miyazaki YI, Kudo FA, Flores J, et al. Prosthetic grafts for above-knee femoropopliteal bypass. A multicenter retrospective study of 564 grafts. Int Angiol 2002;21:145-151.
67. Schweiger H, Klein P, Lang W. Tibial bypass grafting for limb salvage with ringed polytetrafluoroethylene prostheses: results of primary and secondary procedures. J Vasc Surg 1993;18: 867-874.
68. Neville RF, Tempesta B, Sidway AN. Tibial bypass for limb salvage using polytetrafluoroethylene and a distal vein patch. J Vasc Surg 2001;33:266-271.
69. Kreienberg PB, Darling RC III, Chang BB, Paty PS, Lloyd WE, Shah DM. Adjunctive techniques to improve patency of distal prosthetic bypass grafts: polytetrafluoroethylene with remote arteriovenous fistulae versus vein cuffs. J Vasc Surg 2000;31:696-701.
70. Steinthorsson G, Sumpio B. Clinical and biological relevance of vein cuff anastomosis. Acta Chir Belg 1999;99:282-288.
71. Kissin M, Kansal N, Pappas PJ, DeFouw DO, Duran WN, Hobson RW. Vein interposition cuffs decrease the intimal hyperplastic response of polytetrafluoroethylene bypass grafts. J Vasc Surg 2000;31:69-83.
72. Smout JD, Wolfe JH. Venous boot construction for a distal prosthetic bypass. Semin Vasc Surg 2000;13:53-57.
73. Faries PL, Logerfo FW, Arora S, Hook S, Pulling MC, Akbari CM, et al. A comparative study of alternative conduits for lower extremity revascularization: all-autogenous conduit versus prosthetic grafts. J Vasc Surg 2000;32:1080-1090.
74. Deutsch M, Meinhart J, Fischlein T, Preiss P, Zilla P. Clinical autologous in vitro endothelialization of infrainguinal ePTFE grafts in 100 patients: a 9-year experience. Surgery 1999;126: 847-855.
75. Soury P, Peillon C, Watelet J, Planet M, Plissonnier D, Del Gallo G, et al. Prosthetic reinforcement of varicose saphenous vein grafts for infrainguinal bypass. Ann Vasc Surg 1999;13: 290-293.
76. He H, Matsuda T. Newly designed compliant hierarchic hybrid vascular graft wrapped with microprocessed elastomeric film-II: morphogenesis and compliance change upon implantation. Cell Transplant 2002;11:75-87.
77. Bacourt F. Prospective randomized study of carbon-impregnated polytetrafluoroethylene grafts for below-knee popliteal and distal bypass: results at 2 years. The Association Universitaire de Recherche en Chirurgie. Ann Vasc Surg 1997;11: 596-603.
78. Seifalian AM, Tiwari A, Hamilton G, Salacinski HJ. Improving the clinical patency of prosthetic vascular and coronary bypass grafts: the role of seeding and tissue engineering. Artif Organs 2002;26:307-320.
79. Sonoda H, Takamizawa K, Nakayama Y, Yasui H, Matsuda T. Small-diameter compliant arterial graft prosthesis: Design concept of coaxial double tubular graft and its fabrication. J Biomed Mater Res 2001;55:266-276.
80. Fields C, Cassano A, Allen C, Meyer A, Pawlowski KJ, Bowlin GL, et al. Endothelial cell seeding of a 4-mm I.D. polyurethane vascular graft. J Biomater Appl 2002;17:45-70.
81. Aldenhoff YB, Der Veen FH, ter Woorst J, Habets J, Poole-Warren LA, Koole LH. Performance of a polyurethane vascular prosthesis carrying a dipyridamole (Persantin) coating on its lumenal surface. J Biomed Mater Res 2001;54:224-233.
82. Kidane AG, Salacinski HJ, Punshon G, Ramesh B, Srai KS, Seifalian AM. Synthesis and evaluation of amphiphilic RGD derivatives: uses for solvent casting in polymers and tissue engineering applications. Med Biol Eng Comput 2003;41: 740-745.
83. Lauder C, Kelly A, Thompson MM, London NJ, Bell PR, Naylor AR. Early and late outcome after carotid artery bypass grafting with saphenous vein. J Vasc Surg 2003;38:1025-1030.
84. Camiade C, Maher A, Ricco JB, Roumy J, Febrer G, Marchand C, et al. Carotid bypass with polytetrafluoroethylene grafts: a study of 110 consecutive patients. J Vasc Surg 2003; 38:1031-1037.
85. Roddy SP, Darling RC III, Ozsvath KJ, Mehta M, Chang BB, Paty PS, et al. Choice of material for internal carotid artery bypass grafting: vein or prosthetic? Analysis of 44 procedures. Cardiovasc Surg 2002;10:540-544.
86. Ziomek S, Quinones-Baldrich WJ, Busuttil RW, Baker JD, Machleder HI, Moore WS. The superiority of synthetic arterial grafts over autologous veins in carotid-subclavian bypass. J Vasc Surg 1986;3:140-145.
87. Miyamoto K, Sugimoto T, Okada M, Maeda S. Experimental studies on application of small-caliber vascular prosthesis produced by polyurethane. Ann Thorac Cardiovasc Surg 1999;5: 174-181.
88. Phaneuf MD, Dempsey DJ, Bide MJ, Szycher M, Quist WC, Logerfo FW. Bioengineering of a novel small diameter polyurethane vascular graft with covalently bound recombinant hirudin. ASAIO J 1998;44:M653-M658.
89. Walpoth BH, Rogulenko R, Tikhvinskaia E, Gogolewski S, Schaffner T, Hess OM, et al. Improvement of patency rate in heparin-coated small synthetic vascular grafts. Circulation 1998;98:II319-II323.
90. Farrar DJ. Development of a prosthetic coronary artery bypass graft. Heart Surg Forum 2000;3:36-40.
91. Hehrlein FW, Schlepper M, Loskot F, Scheid HH, Walter P, Mulch J. The use of expanded polytetrafluoroethylene (PTFE) grafts for myocardial revascularization. J Cardiovasc Surg (Torino) 1984;25:549-553.
92. Chard RB, Johnson DC, Nunn GR, Cartmill TB. Aorta-coronary bypass grafting with polytetrafluoroethylene conduits. Early and late outcome in eight patients. J Thorac Cardiovasc Surg 1987;94:132-134.
93. Okoshi T, Soldani G, Goddard M, Galletti PM. Very small-diameter polyurethane vascular prostheses with rapid endothelialization for coronary artery bypass grafting. J Thorac Cardiovasc Surg 1993;105:791-795.
94. Lambert AW, Fox AD, Williams DJ, Horrocks M, Budd JS. Experience with heparin-bonded collagen-coated grafts for infrainguinal bypass. Cardiovasc Surg 1999;7:491-494.
95. Devine C, Hons B, McCollum C. Heparin-bonded Dacron or polytetrafluoroethylene for femoropopliteal bypass grafting: a multicenter trial. J Vasc Surg 2001;33:533-539.
96. Dereume JP, van Romphey A, Vincent G, Engelmann E. Femoropopliteal bypass with a compliant, composite polyurethane/Dacron graft: short-term results of a multicentre trial. Cardiovasc Surg 1993;1:499-503.
97. Garcia-Pajares R, Polo JR, Flores A, Gonzalez-Tabares E, Sous JV. Upper arm polytetrafluoroethylene grafts for dialysis access. Analysis of two different graft sizes: 6 mm and 6-8 mm. Vasc Endovascular Surg 2003;37:335-343.
98. Allen RD, Yuill E, Nankivell BJ, Francis DM. Australian multicentre evaluation of a new polyurethane vascular access graft. Aust N Z J Surg 1996;66:738-742.
99. Glickman M, Gheissari A, Money S, Martin J, Ballard JL. A polymeric sealant inhibits anastomotic suture hole bleeding more rapidly than gelfoam/thrombin: results of a randomized controlled trial. Arch Surg 2002;137:326-331.
100. McLarty AJ, Phillips MR, Holmes DR Jr, Schaff HV. Aortocoronary bypass grafting with expanded polytetrafluoroethylene: 12-year patency. Ann Thorac Surg 1998;65:1442-1444.
101. Hallman G, Cooley Da, Mcnamara Dg, Latson JR. Single left coronary artery with fistula to right ventricle: reconstruction of two-coronary system with dacron graft. Circulation 1965;32: 293-297.
102. Sauvage LR, Schloemer R, Wood SJ, Logan G. Successful interposition synthetic graft between aorta and right coronary artery. Angiographic follow-up to sixteen months. J Thorac Cardiovasc Surg 1976;72:418-421.
103. Yokoyama T, Gharavi MA, Lee YC, Edmiston WA, Kay JH. Aorta-coronary artery revascularization with an expanded polytetrafluoroethylene vascular graft. A preliminary report. J Thorac Cardiovasc Surg 1978;76:552-555.
104. Kerber S, Baumbach M, Rahmel A, Weyand M, Scheid HH, Breithardt G. Clinical and invasive 7-month follow-up of a patient with a synthetic coronary graft. Int J Cardiol 1995;51: 143-147.
105. Rashid ST, Salacinski HJ, Button MJ, Fuller B, Hamilton G, Seifalian AM. Cellular engineering of conduits for coronary and lower limb bypass surgery: role of cell attachment peptides and pre-conditioning in optimising smooth muscle cells (SMC) adherence to compliant poly(carbonate-urea)urethane (MyoLink) scaffolds. Eur J Vasc Endovasc Surg 2004;27: 608-616.
106. Phillips MR, Yamaguchi H, Miller VM, Williams S, Morris JJ, Schaff HV. Endothelial sodding of the Permaflow prosthetic coronary artery bypass conduit. Ann Thorac Surg 1998;66: 1191-1197.
107. Laube HR, Duwe J, Rutsch W, Konertz W. Clinical experience with autologous endothelial cell-seeded polytetrafluoroethylene coronary artery bypass grafts. J Thorac Cardiovasc Surg 2000;120:134-141.
108. Laube HR, Matthaus M. A new semi-automatic endothelial cell seeding technique for biological prosthetic heart valves. Int J Artif Organs 2001;24:243-246.
109. Flarup S, Hadimeri H. Arteriovenous PTFE dialysis access in the lower extremity: a new approach. Ann Vasc Surg 2003; 17:581-584.
110. Dammers R, Planken RN, Pouls KP, Van Del RJ, Burger H, Van Der Sande FM, et al. Evaluation of 4-mm to 7-mm versus 6-mm prosthetic brachial-antecubital forearm loop access for hemodialysis: results of a randomized multicenter clinical trial. J Vasc Surg 2003;37:143-148.
111. Gibson KD, Gillen DL, Caps MT, Kohler TR, Sherrard DJ, Stehman-Breen CO. Vascular access survival and incidence of revisions: a comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the United States Renal Data System Dialysis Morbidity and Mortality Study. J Vasc Surg 2001;34:694-700.
112. Senkaya I, Aytac II, Eercan AK, Aliosman A, Percin B. The graft selection for haemodialysis. Vasa 2003;32:209-213.
113. Mall JW, Philipp AW, Rademacher A, Paulitschke M, Buttemeyer R. Re-endothelialization of punctured ePTFE graft: an in vitro study under pulsed perfusion conditions. Nephrol Dial Transplant 2004;19:61-67.
114. Berard X, Baste JC, Sassoust G, Du BL, Combe C, De PV, et al. Retrospective study of the one-year patency of a cuffed polytetrafluoroethylene Venaflo-type graft placed for venous hemodialysis access. J Mal Vasc 2003;28:73-78.
115. Sorom AJ, Hughes CB, McCarthy JT, Jenson BM, Prieto M, Panneton JM, et al. Prospective, randomized evaluation of a cuffed expanded polytetrafluoroethylene graft for hemodialysis vascular access. Surgery 2002;132:135-140.
116. Wiese P, Blume J, Mueller HJ, Renner H, Nonnast-Daniel AB. Clinical and Doppler ultrasonography data of a polyurethane vascular access graft for haemodialysis: a prospective study. Nephrol Dial Transplant 2003;18:1397-1400.
117. Phaneuf MD, Dempsey DJ, Bide MJ, Quist WC, Logerfo FW. Coating of Dacron vascular grafts with an ionic polyurethane: a novel sealant with protein binding properties. Biomaterials 2001;22:463-469.
118. Peng CW, Tan SG. Polyurethane grafts: a viable alternative for dialysis arteriovenous access? Asian Cardiovasc Thorac Ann 2003;11:314-318.
119. Kiyama H, Imazeki T, Kurihara S, Yoneshima H. Long-term follow-up of polyurethane vascular grafts for hemoaccess bridge fistulas. Ann Vasc Surg 2003;17:516-521.
120. Wilson SE. New alternatives in management of the infected vascular prosthesis. Surg Infect (Larchmt) 2001;2: 171-175.
121. Bos GW, Pool AA, Beugeling T, van Aken WG, Feijen J. Small-diameter vascular graft prostheses: current status. Arch Physiol Biochem 1998;106:100-115.
122. Salacinski H, Tiwari A, Hamilton G, Seifalian AM. Performance of a polyurethane vascular prosthesis carrying a dipyridamole (Persantin) coating on its lumenal surface. J Biomed Mater Res 2002;61:337-338.
123. Salacinski HJ, Hamilton G, Seifalian AM. Surface functionalization and grafting of heparin and/or RGD by an aqueous-based process to a poly(carbonate-urea)urethane cardiovascular graft for cellular engineering applications. J Biomed Mater Res 2003;66A:688-697.
124. Cassell OC, Hofer SO, Morrison WA, Knight KR. Vascularisation of tissue-engineered grafts: the regulation of angiogenesis in reconstructive surgery and in disease states. Br J Plast Surg 2002;55:603-610.
125. Salacinski HJ, Tai NR, Punshon G, Giudiceandrea A, Hamilton G, Seifalian AM. Optimal endothelialisation of a new compliant poly(carbonate-urea)urethane vascular graft with effect of physiological shear stress. Eur J Vasc Endovasc Surg 2000;20:342-352.
126. Salacinski HJ, Punshon G, Krijgsman B, Hamilton G, Seifalian AM. A hybrid compliant vascular graft seeded with microvascular endothelial cells extracted from human omentum. Artif Organs 2001;25:974-982.
127. Kidd KR, Patula VB, Williams SK. Accelerated endothelialization of interpositional 1-mm vascular grafts. J Surg Res 2003;113:234-242.
128. Urry DW, Pattanaik A. Elastic protein-based materials in tissue reconstruction. Ann N Y Acad Sci 1997;831:32-46.
129. Kikuchi A, Okuhara M, Karikusa F, Sakurai Y, Okano T. Two-dimensional manipulation of confluently cultured vascular endothelial cells using temperature-responsive poly(N-isopropylacrylamide)-grafted surfaces. J Biomater Sci Polym Ed 1998;9:1331-1348.
130. Tiwari A, Salacinski H, Seifalian AM, Hamilton G. New prostheses for use in bypass grafts with special emphasis on polyurethanes. Cardiovasc Surg 2002;10:191-197.
131. Baguneid M, Murray D, Salacinski HJ, Fuller B, Hamilton G, Walker M, Seifalian AM. Shear-stress preconditioning and tissue engineering-based paradigms for generating arterial substitutes. Biotechnol Appl Biochem 2004;39:151-157.